Cadila Healthcare reports 54% rise in Q4 consolidated net profit

01 Jun 2013 Evaluate

Cadila Healthcare has reported results for the fourth quarter and year ended March 31, 2013.

The company has reported a rise of 45.29% in its net profit at Rs 202.53 crore in Q4FY13 as compared to net profit of Rs 139.40 crore in the same quarter previous year. Total income from operation of the company has increased by 21.61% to Rs 965.17 crore as compared to Rs 793.67 crore in corresponding quarter last year.

On consolidated basis, the company has reported a rise of 53.59% in its net profit at Rs 262.46 crore in Q4FY13 as compared to net profit of Rs 170.88 crore in the same quarter previous year. Total income from operation of the company has increased by 14.66% to Rs 1620.63 crore as compared to Rs 1413.38 crore in corresponding quarter last year.

For the year ended March 31, 2013, the company has registered 29.03% fall in its net profit at Rs 466.64 crore in FY13 as against Rs 657.52 crore in previous years. However, total income from operation of the company has increased to Rs 3440.41 crore as compared to Rs 3387.73 crore in FY12, up by 1.55%.

On consolidated basis, for the full year ended March 31, 2013, the company has posted a 0.41% rise in its net profit at Rs 655.30 crore under year under review as compared to Rs 652.59 crore in FY12. Total income has increased by 20.34% at Rs 6395.08 crore for year under review as compared to Rs 5314.26 crore for the period ended March 31, 2012.

Zydus Lifesciences Share Price

931.45 -3.75 (-0.40%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×